BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10744647)

  • 1. Control of CD4 T cell fate by antigen re-stimulation with or without CTLA-4 engagement 24 h after priming.
    Nakata Y; Uzawa A; Suzuki G
    Int Immunol; 2000 Apr; 12(4):459-66. PubMed ID: 10744647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-responsiveness of antigen-experienced CD4 T cells reflects more stringent co-stimulatory requirements.
    Hamel ME; Noteboom E; Kruisbeek AM
    Immunology; 1998 Mar; 93(3):366-75. PubMed ID: 9640247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superantigen-induced regulatory T cells display different suppressive functions in the presence or absence of natural CD4+CD25+ regulatory T cells in vivo.
    Grundström S; Cederbom L; Sundstedt A; Scheipers P; Ivars F
    J Immunol; 2003 May; 170(10):5008-17. PubMed ID: 12734345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
    Zhou T; Weaver C; Linsley PS; Mountz JD
    Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polarization of naive CD4+ T cells toward the Th1 subset by CTLA-4 costimulation.
    Kato T; Nariuchi H
    J Immunol; 2000 Apr; 164(7):3554-62. PubMed ID: 10725710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic exposure to superantigen induces regulatory CD4(+) T cells with IL-10-mediated suppressive activity.
    Noël C; Florquin S; Goldman M; Braun MY
    Int Immunol; 2001 Apr; 13(4):431-9. PubMed ID: 11282982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4(+)CD25(+) T cells facilitate the induction of T cell anergy.
    Ermann J; Szanya V; Ford GS; Paragas V; Fathman CG; Lejon K
    J Immunol; 2001 Oct; 167(8):4271-5. PubMed ID: 11591749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity.
    Steinbrink K; Graulich E; Kubsch S; Knop J; Enk AH
    Blood; 2002 Apr; 99(7):2468-76. PubMed ID: 11895781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of T cell anergy in the absence of CTLA-4/B7 interaction.
    Frauwirth KA; Alegre ML; Thompson CB
    J Immunol; 2000 Mar; 164(6):2987-93. PubMed ID: 10706686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anergy in peripheral memory CD4(+) T cells induced by low avidity engagement of T cell receptor.
    Mirshahidi S; Huang CT; Sadegh-Nasseri S
    J Exp Med; 2001 Sep; 194(6):719-31. PubMed ID: 11560989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
    Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
    Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.
    Wells AD; Walsh MC; Bluestone JA; Turka LA
    J Clin Invest; 2001 Sep; 108(6):895-903. PubMed ID: 11560959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).
    Griffin MD; Hong DK; Holman PO; Lee KM; Whitters MJ; O'Herrin SM; Fallarino F; Collins M; Segal DM; Gajewski TF; Kranz DM; Bluestone JA
    J Immunol; 2000 May; 164(9):4433-42. PubMed ID: 10779742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CTLA-4 in regulating Th2 differentiation.
    Oosterwegel MA; Mandelbrot DA; Boyd SD; Lorsbach RB; Jarrett DY; Abbas AK; Sharpe AH
    J Immunol; 1999 Sep; 163(5):2634-9. PubMed ID: 10453003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+CD25+ and CD4+CD25- T cells act respectively as inducer and effector T suppressor cells in superantigen-induced tolerance.
    Feunou P; Poulin L; Habran C; Le Moine A; Goldman M; Braun MY
    J Immunol; 2003 Oct; 171(7):3475-84. PubMed ID: 14500643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA-4 regulates tolerance induction and T cell differentiation in vivo.
    Walunas TL; Bluestone JA
    J Immunol; 1998 Apr; 160(8):3855-60. PubMed ID: 9558090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of CTL responses by simultaneous administration of liposomal peptide vaccine with anti-CD40 and anti-CTLA-4 mAb.
    Ito D; Ogasawara K; Iwabuchi K; Inuyama Y; Onoé K
    J Immunol; 2000 Feb; 164(3):1230-5. PubMed ID: 10640735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD152 ligation by CD80 on T cells is required for the induction of unresponsiveness by costimulation-deficient antigen presentation.
    Chai JG; Vendetti S; Amofah E; Dyson J; Lechler R
    J Immunol; 2000 Sep; 165(6):3037-42. PubMed ID: 10975813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of CTLA-4 signals inhibits Th2-mediated murine chronic graft-versus-host disease by an enhanced expansion of regulatory CD8+ T cells.
    Sakurai J; Ohata J; Saito K; Miyajima H; Hirano T; Kohsaka T; Enomoto S; Okumura K; Azuma M
    J Immunol; 2000 Jan; 164(2):664-9. PubMed ID: 10623808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.
    Perez VL; Van Parijs L; Biuckians A; Zheng XX; Strom TB; Abbas AK
    Immunity; 1997 Apr; 6(4):411-7. PubMed ID: 9133420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.